Newspaper Publication of Audited Financial Results for the fourth quarter and year ended on March 31, 2026.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Corona Remedies Limited has published its audited financial results for Q4 and full year FY2026 (ended March 31, 2026) in Financial Express newspapers (English and Gujarati editions) on May 12, 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting on May 11, 2026. The company transitioned from Corona Remedies Private Limited to Corona Remedies Limited (listed company). The statutory audit was conducted by Deloitte Haskins & Sells LLP. The filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 47 requirements for newspaper publication of financial results.
This is a mandatory compliance filing confirming the company has published its annual and quarterly financial results in newspapers as required by SEBI listing regulations. The actual financial performance figures and any commentary on business performance would be contained in the full financial results document, which is referenced as available on the company website and stock exchange portals.